Responsiveness and minimal clinically important differences after cholecystectomy: GIQLI versus SF-36

Area of Science:

• Gastroenterology
• Health Outcomes Research
• Surgical Outcomes

Background:

• Assessing patient-reported outcomes after surgery is crucial.
• Comparing disease-specific and generic health status measures is important for accurate evaluation.

Purpose of the Study:

• To compare the responsiveness and minimal clinically important differences (MCID) of the GIQLI and SF-36.
• To determine the superiority of disease-specific versus generic measures in post-cholecystectomy patients.

Main Methods:

• Prospective analysis of 159 patients undergoing cholecystectomy.
• Administration of GIQLI and SF-36 questionnaires pre- and post-surgery.
• Statistical analysis using generalized estimating equations and bootstrap estimation.

Main Results:

• Both GIQLI and SF-36 showed statistically significant improvements post-surgery.
• GIQLI demonstrated superior responsiveness compared to SF-36, evidenced by effect size and standardized response means.
• MCID analysis indicated good clinical relevance for both instruments, with significant differences in specific domains.

Conclusions:

• The GIQLI is a more responsive measure than the SF-36 for evaluating outcomes in patients after cholecystectomy.
• Disease-specific measures should be prioritized over generic measures for assessing treatment effectiveness in clinical practice and research.